Master Digoxin Mechanism and Indication with Picmonic for Medicine

A decrease of this gradient leads to indirect inhibition of the Na/Ca exchanger, which depends on a constant inward sodium gradient to pump calcium out of myocytes. Therefore, digoxin decreases the sodium concentration gradient and indirectly decreases subsequent calcium outflow.

Digoxin decreases the sodium concentration gradient and indirectly decreases subsequent calcium outflow. This results in increased calcium concentration in the heart cells, which leads to increased contractility of the heart. This is also referred to as increased positive inotropy.

Digoxin decreases the sodium concentration gradient and indirectly decreases subsequent calcium outflow. This results in increased calcium concentration in the heart cells, which leads to increased contractility of the heart. This is also referred to as increased positive inotropy.

Because digoxin can increase the ionotropy/contractility of the heart, it is sometimes used in patients who have congestive heart failure who remain symptomatic despite adequate diuretic and ACE inhibitor treatment. It is important to note it is not a first line treatment of CHF and has not shown to improve mortality in patients with CHF.

There is also evidence that digoxin increases vagal activity, thereby decreasing heart rate by slowing depolarization of pacemaker cells in the AV node.

There is also evidence that digoxin increases vagal activity, thereby decreasing heart rate by slowing depolarization of pacemaker cells in the AV node.

Slowed conduction through the AV node makes this drug commonly used in the treatment of atrial fibrillation with rapid ventricular response. In atrial fibrillation, rapid ventricular rate leads to insufficient diastolic filling time. By slowing down the conduction in the AV node, digoxin can reduce ventricular rate therefore improving ventricular filling and the pumping function of the heart.